What is ExaCare?
ExaCare AI is purpose-built for skilled nursing facilities, offering an agentic solution designed to streamline the post-acute admissions process. The platform ingests referral data, surfaces critical insights, and standardizes decision-making workflows. This enables healthcare teams to expedite admissions, ensuring patients receive care sooner. The company's focus on leveraging artificial intelligence to address inefficiencies in healthcare logistics positions it as a key player in the health tech landscape, aiming to improve both patient outcomes and facility operational capacity.
How much funding has ExaCare raised?
ExaCare has raised a total of $30M across 1 funding round:
Series A
$30M
Series A (2025): $30M with participation from Insight Partners, Bienville Capital Management, and Foundation Capital
Key Investors in ExaCare
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies, focusing on enterprise software, SaaS, and internet platforms.
Bienville Capital Management
Bienville operates as an investment firm delivering asset management and advisory services across public and private markets, serving institutional investors, family offices, and entrepreneurs with tailored investment strategies.
Foundation Capital
Foundation Capital is a venture capital firm that partners with founders building category-defining technology companies, supporting entrepreneurs from the earliest stages through long-term growth with deep operational and strategic expertise.
What's next for ExaCare?
With this substantial enterprise-level backing, ExaCare is poised for accelerated expansion and further development of its AI capabilities. The recent strategic investment, likely a Series A round given the context, suggests the company is moving beyond its initial development phase and into a scaling phase. This capital will likely be deployed to enhance its technology, broaden its market reach within the skilled nursing facility sector, and potentially explore adjacent healthcare markets. The focus on "saying 'yes' faster" indicates a strategic imperative to capture market share by demonstrating clear ROI through improved admission speed and efficiency.
See full ExaCare company page
